Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.11
+0.01 (0.16%)
Aug 10, 2026, 11:25 AM EDT - Market open
Wave Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 65.37 | 42.73 | 108.3 | 113.31 | 3.65 | 40.96 | |
Revenue Growth | -30.42% | -60.55% | -4.42% | 3005.10% | -91.09% | 104.03% |
Gross Profit | 65.37 | 42.73 | 108.3 | 113.31 | 3.65 | 40.96 |
Selling, General & Admin | 85.87 | 75.33 | 59.02 | 51.29 | 50.51 | 46.11 |
Research & Development | 197.42 | 182.78 | 159.68 | 130.01 | 115.86 | 121.88 |
Total Operating Expenses | 283.29 | 258.11 | 218.71 | 181.3 | 166.37 | 167.98 |
Operating Income | -217.92 | -215.38 | -110.4 | -68 | -162.72 | -127.02 |
Interest Income | 12.19 | 10.48 | 10.16 | 7.93 | 1.57 | 0.03 |
Other Non-Operating Income (Expense) | 0.2 | 0.53 | 3.23 | 1.88 | 0.01 | 4.54 |
Total Non-Operating Income (Expense) | 15.45 | 11.01 | 13.4 | 9.81 | 1.58 | 4.57 |
Pretax Income | -202.47 | -204.38 | -97.01 | -58.19 | -161.14 | -122.45 |
Net Income | -202.47 | -204.38 | -97.01 | -57.51 | -161.82 | -122.25 |
Net Income to Common | -202.47 | -204.38 | -97.01 | -57.51 | -161.82 | -122.25 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 188 | 169 | 138 | 106 | 79 | 52 |
Shares Outstanding (Diluted) | 188 | 169 | 138 | 106 | 79 | 52 |
Shares Change | 19.11% | 21.96% | 30.33% | 34.55% | 52.16% | 32.12% |
EPS (Basic) | -1.09 | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 |
EPS (Diluted) | -1.09 | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -193.15 | -188.21 | -151.96 | -20.55 | -129.14 | -89.55 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.03 | -1.12 | -1.10 | -0.19 | -1.64 | -1.73 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -333.36% | -504.09% | -101.94% | -60.01% | -4459.30% | -310.07% |
Profit Margin | -309.73% | -478.34% | -89.57% | -50.76% | -4434.72% | -298.42% |
FCF Margin | -295.46% | -440.50% | -140.31% | -18.13% | -3539.11% | -218.61% |
EBITDA | -214.52 | -211.94 | -106.51 | -63 | -156.15 | -119.53 |
EBITDA Margin | -328.16% | -496.04% | -98.34% | -55.60% | -4279.14% | -291.80% |
EBIT | -217.92 | -215.38 | -110.4 | -68 | -162.72 | -127.02 |
EBIT Margin | -333.36% | -504.09% | -101.94% | -60.01% | -4459.30% | -310.07% |